Shortly, the significant difference in CERT1 between the OB-MetS− or OB-MetS+ and NW groups, evidenced by ANOVA previously described (Figure 1), was maintained when the covariates HOMA-IR and CRP were simultaneously considered (i.e., HOMA-IR + CRP). This evidence concerns the gene CERT1 and metabolic syndrome.